Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 1.00 |
| ▸ | PPARG | P37231 | 6/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 4/20 | 1.00 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.77 |
| ▸ | F7 | P08709 | 4/20 | 0.77 |
| ▸ | F3 | P13726 | 4/20 | 0.77 |
| ▸ | PPARD | Q03181 | 4/20 | 0.77 |
| ▸ | PPARA | Q07869 | 4/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Doconexent SCHEMBL288136 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185492 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18274973 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185536 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL14546282 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185432 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185380 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185510 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185468 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 | |
| Doconexent SCHEMBL18185516 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGCYP19A1MAPTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230097753-A1 | ALPHA-HYDROXYLATED FATTY-ACID METABOLITES, MEDICAL USES AND USE AS BIOMARKERS | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2023-03-30 | — | — | US | disclosed |
| EP-4098649-A2 | ALPHA-HYDROXYLATED FATTY-ACID METABOLITES, MEDICAL USES OF SAME AND USE AS BIOMARKERS | Universitat de les Illes Balears (ES) | 2022-12-07 | — | — | EP | disclosed |
| CN-115052852-A | Alpha-hydroxylated fatty acid metabolites, medical uses thereof, and uses as biomarkers | 巴利阿里群岛大学 | 2022-09-13 | — | — | CN | disclosed |
| US-9290486-B1 | Compositions and methods for the treatment of epilepsy | CELLIX BIO PRIVATE LIMITED (IN) | 2016-03-22 | — | — | US | disclosed |
| US-9290486-B1 | Compositions and methods for the treatment of epilepsy | CELLIX BIO PRIVATE LIMITED (IN) | 2016-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230097753-A1 | ALPHA-HYDROXYLATED FATTY-ACID METABOLITES, MEDICAL USES AND USE AS BIOMARKERS | FABP1, CYP27A1, FABP2 | ALDH1A1 129/4885PPARG 115/4885CYP19A1 161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.